AUTOLOGOUS BONE MARROW TRANSPLANTATION

High-dose chemotherapy with autologous stem cell support is increasingly used in malignant disease. There are few data from randomized, controlled, clinical studies on which to base our approach, and many publications consist of retrospective analyses that do not help elucidate the overall role of high-dose therapy. There has been a rapid increase in the use of peripheral blood as a source of stem cells that may reduce the toxicity of the procedure, but this has spawned an enthusiasm for high-dose therapy particularly in conditions such as myeloma and solid tumors where, as yet, there are few clinical data to demonstrate survival benefit.

[1]  J. Fahey,et al.  Bone-marrow transplantation in acute leukaemia. , 1977, Lancet.

[2]  Michelle R Jones,et al.  Double Ablative Chemotherapy with Autologous Marrow Rescue in the Treatment of Acute Leukaemia , 1984 .

[3]  J. Reiffers,et al.  Serial probability analysis of the 1982 revised criteria for the classification of systemic lupus erythematosus. , 1983 .

[4]  J. Griffin,et al.  Use of surface markers to identify a subset of acute myelomonocytic leukemia cells with progenitor cell properties. , 1983, Blood.

[5]  M. Valdivieso,et al.  High‐dose chemotherapy and autologous bone marrow transplantation for the treatment of small cell lung carcinoma , 1983, Cancer.

[6]  P. Biron,et al.  Massive BACT chemotherapy with autologous bone marrow transplantation in 17 cases of non-Hodgkin's malignant lymphoma with a very bad prognosis. , 1983, European journal of cancer & clinical oncology.

[7]  A. Burnett,et al.  Haematological reconstitution following high dose and supralethal chemo‐radiotherapy using stored, non‐cryopreserved autologous bone marrow , 1983, British journal of haematology.

[8]  E. Ronge-Collard,et al.  Granulocyte‐macrophage progenitor cell preservation at 4°C , 1983, British journal of haematology.

[9]  J. Goldman,et al.  Philadelphia chromosome-negative progenitors in chronic granulocytic leukemia. , 1983, The New England journal of medicine.

[10]  F. Cabanillas,et al.  IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy. , 1982, Blood.

[11]  R. Bast,et al.  AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENT , 1982, The Lancet.

[12]  E. Klein,et al.  Specificity of auto‐tumor cytotoxicity exerted by fresh, activated and propagated human t lymphocytes , 1982, International journal of cancer.

[13]  G. Janossy,et al.  A technique for rapid isolation of bone marrow mononuclear cells using Ficoll‐Metrizoate and the IBM 2991 blood cell processor , 1982, British journal of haematology.

[14]  D. Linch,et al.  Bone marrow processing and cryopreservation. , 1982, Journal of clinical pathology.

[15]  M. Aglietta,et al.  DISAPPEARANCE OF PHILADELPHIA CHROMOSOME AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION FOR TREATMENT OF CHRONIC MYELOID LEUKAEMIA IN ACUTE CRISIS , 1982, The Lancet.

[16]  J. Graham-Pole,et al.  High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma. , 1982, British Journal of Cancer.

[17]  F. Frassoni,et al.  High Dose BCNU Followed by Autologous Bone Marrow Infusion in Glioblastoma Multiforme , 1981, Tumori.

[18]  R. Storb,et al.  Treatment of non-Hodgkin's lymphoma with marrow transplantation in identical twins. , 1981, Blood.

[19]  P. Burke,et al.  Successful engraftment of blood derived normal hemopoietic stem cells in chronic myelogenous leukemia. , 1981, Experimental hematology.

[20]  A. Zander,et al.  The treatment of advanced testicular carcinoma with high dose chemotherapy and autologous marrow support. , 1981, European journal of cancer.

[21]  E. Frei,et al.  Dose: a critical factor in cancer chemotherapy. , 1980, The American journal of medicine.

[22]  R. Winchester,et al.  Continuous human bone marrow culture: Ia antigen characterization of probable pluripotential stem cells. , 1980, Blood.

[23]  R. Oldham,et al.  SMALL-CELL CARCINOMA OF THE BRONCHUS , 1980, The Lancet.

[24]  S. Sharkis,et al.  Elimination of acute myelogenous leukemic cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide. , 1980, Blood.

[25]  G. Witman,et al.  Diffuse histiocytic lymphoma: a potentially curable disease. , 1980, Connecticut medicine.

[26]  P. Neiman,et al.  Marrow transplantation for acute nonlymphoblastic leukemia in first remission. , 1979, The New England journal of medicine.

[27]  J. Petit,et al.  High dose combination chemotherapy (TACC) with and without autologous bone marrow transplantation for the treatment of acute leukaemia and other malignant diseases: kinetics of recovery of haemopoiesis. A preliminary study of 12 cases. , 1979, European journal of cancer.

[28]  A. Zander,et al.  High-dose BCNU therapy with autologous bone marrow infusion: preliminary observations. , 1979, Cancer treatment reports.

[29]  D. Hedley,et al.  Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan. , 1979, British Journal of Cancer.

[30]  M. Cline,et al.  A technique for the separation and cryopreservation of myeloid stem cells from human bone marrow. , 1979, Cryobiology.

[31]  L. Peters,et al.  AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN RELAPSED ADULT ACUTE LEUKÆMIA , 1979, The Lancet.

[32]  A. Zander,et al.  Autologous bone-marrow transplantation in relapsed adult acute leukaemia. , 1979, Lancet.

[33]  F. Appelbaum,et al.  Prolonged complete remission following high dose chemotherapy of burkitt's lymphoma in relapse , 1978, Cancer.

[34]  N. Gorin,et al.  Long-term preservation of bone marrow and stem cell pool in dogs. , 1978, Blood.

[35]  G. Klein,et al.  Further studies on the differences in serum dependence in EBV negative lymphoma lines and their in vitro EBV converted, virus-genome carrying sublines. , 1977, European journal of cancer.

[36]  J. Till,et al.  COLONY ASSAY FOR PROLIFERATIVE BLAST CELLS CIRCULATING IN MYELOBLASTIC LEUKÆMIA , 1977, The Lancet.

[37]  R. Weiner,et al.  Cryopreserved autologous marrow infusion following high dose cancer chemotherapy. , 1977, European journal of cancer.

[38]  P. Neiman,et al.  Cure of leukemia by marrow transplantation , 1977 .

[39]  F. Bach,et al.  Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells , 1976, Nature.

[40]  V. Devita,et al.  ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASE RESULTS WITH COMBINATION CHEMOTHERAPY , 1975, The Lancet.

[41]  W. R. Bruce,et al.  Comparison of the Sensitivity of Normal Hematopoietic and Transplanted Lymphoma Colony-Forming Cells to Chemotherapeutic Agents Administered In Vivo , 1966 .

[42]  J. G. Humble,et al.  The Clinical Application of Bone Marrow Grafting , 1962, British Journal of Cancer.

[43]  J. G. Humble,et al.  The Clinical Application of Bone Marrow Grafting , 1962, British Journal of Cancer.

[44]  W. Dameshek,et al.  Autologous bone marrow infusion as an adjunct in therapy of malignant disease. , 1959, Blood.

[45]  J. Gerdes,et al.  Some observations on the treatment of postirradiation hematopoietic depression in man by the infusion of stored autogenous bone marrow. , 1959, Annals of internal medicine.